First Citizens BancShares Inc vs GSK plc — how do they compare? First Citizens BancShares Inc trades at $2,162.83 (market cap $23.76B), while GSK plc trades at $52.7 (market cap $101.34B). The key difference: GSK plc is far larger — about 4.3× First Citizens BancShares Inc's market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| FCNCA | GSK | |
|---|---|---|
Market Cap | $23.76B | $101.34B |
Sector | Sector/Thematic | Health |
52-Week High | $2.20K | $61.18 |
52-Week Low | $1.64K | $36.20 |
Dividend Yield | 0.41% | 3.49% |
Enterprise Value | — | $121.95B |
Signals from Pluang's Aura AI — not financial advice
First Citizens BancShares (FCNCA) trades at $2,166.64, up 5.06% today, with a neutral technical signal and bullish moving averages. The company reported strong Q1 2026 earnings of $44.86 per share, beating estimates, and maintains a solid net income margin of 24.35%. Recent news includes a planned rebranding of Silicon Valley Bank and expansion of commercial banking capabilities.
Outlook remains stable with consistent revenue near $9.3B and profit growth. Risks include margin pressure and credit trends, but analyst consensus is a $2,320 price target with a hold-heavy rating. The stock presents a value opportunity with a low P/E of 11.94, though investor sentiment is cautious amid sector challenges.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →